The Use of Lipid-Based Formulations to Increase the Oral Bioavailability of Panax Notoginseng Saponins Following a Single Oral Gavage to Rats

REFERENCES

• Aungst B. J., Saitoh H., Burchman D. L., Huang S.-M., Mousa S. A., Hussain M. A. Enhancement of the intestinal absorption of peptides and nonpeptides. J. Control. Release 1996; 41: 19–31
   Web of Science ®Google Scholar
• Benishin C. G., Lee R., Wang L. C., Liu H. J. Effects of ginsenoside Rb1 on central cholinergic metabolism. Pharmacology 1991; 42: 223–229
   PubMed Web of Science ®Google Scholar
• Beskid G., Unowsky J., Behl C. R., Siebelist J., Tossounian J. L., McGarry C. M., et al. Enteral, oral, and rectal absorption of ceftriaxone using glyceride enhancers. Chemotherapy 1988; 34: 77–84
   PubMed Web of Science ®Google Scholar
• Buhlmayer P., Caselli A., Fuhrer W., Goschkler R., Rasetti V., Rueger H., et al. Synthesis and biological activity of some transition-state inhibitors of human renin. J. Med. Chem. 1988; 31: 1839–1846
   PubMed Web of Science ®Google Scholar
• Caliph S. M., Charman W. N., Porter C. J. H. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J. Pharm. Sci. 2000; 89: 1073–1084
   PubMed Web of Science ®Google Scholar
• Constanitinides P. P., Scalart J. P., Lancaster C., Marcello J., Marks G., Ellens H., et al. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm. Res. 1994; 11: 1385–1390
   PubMed Web of Science ®Google Scholar
• Cournarie F., Auchere D., Chevenne D., Lacour B., Seiller M., Vauthir C. Absorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats. Int. J. Pharm. 2002; 242: 325–328
   PubMed Web of Science ®Google Scholar
• Fukui E., Kurohara H., Kageyu A., Kurosaki Y., Nakayama T., Kimura T. Enhancing effect of medium-chain triglycerides on intestinal absorption of d-alpha-tocopherol acetate from lecithindispersed solutions in the rat. J. Pharmacobio-dyn. 1989; 12: 80–86
   PubMedGoogle Scholar
• Han M., Fang X.-L. Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models. Acta Pharmacol. Sin. 2006; 27: 499–505
   PubMed Web of Science ®Google Scholar
• Han M., Sha X., Wu Y., Fang X. Oral absorption of ginsenoside Rb1 using in vitro and in vivo models. Planta Med. 2006; 72: 398–404
   PubMed Web of Science ®Google Scholar
• Hasegawa H., Sung J. H., Matsumiya S., Uchiyama M. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med. 1996; 62: 453–457
   PubMed Web of Science ®Google Scholar
• Kanaoks M., Akao T., Kobashi K. Metabolism of ginseng saponins, ginsenoside, by human intestinal flora. J. Traditional Medicine 1994; 11: 241–246
   Google Scholar
• Kiyasu J. Y., Bloom B., Chaikoff I. L. The portal transport of absorbed fatty acids. J. Biol. Chem. 1952; 199: 415–419
   PubMed Web of Science ®Google Scholar
• Kleinert H. D., Rosenberg S. H., Baker W. R., Stein H. H., Klinghofer V., Barlow J., et al. Discovery of a peptide-based renin inhibitor with oral bioavailability and efficacy. Science 1992; 257: 1940–1943
   PubMed Web of Science ®Google Scholar
• Lee V. H. L. Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J. Control. Release 1990; 13: 213–223
   Web of Science ®Google Scholar
• Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001; 46: 3–26
   PubMed Web of Science ®Google Scholar
• Lohikangas L., Wilen M., Einarsson M., Artursson P. Effects of a new lipid-based drug delivery system on the absorption of low molecular weight heparin (Fragmin) through mnnolayers of human intestinal epithelial Caco-2 cells and after rectal administration to rabbits. Eur. J. Pharm. Sci. 1994; 1: 297–305
   Web of Science ®Google Scholar
• Muramatsu K., Maitani Y., Nagai T. Dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols and cholesterol as a carrier for the oral administration of insulin in rats. Biol. Pharm. Bull. 1996; 19: 1055–1058
   PubMed Web of Science ®Google Scholar
• Nankervis R., Davis S. S., Day N. H., Shaw P. N. Intestinal lymphatic transport of three retinoids in the rat after oral administration: effect of lipophilicity and lipid vehicle. Int. J. Pharm. 1996; 130: 57–64
   Web of Science ®Google Scholar
• New R. R. C., Kirby C. J. Solubilisation aids. U.S. Patent 5968549, 1999
   Google Scholar
• Odani T., Tanizawa H., Takino Y. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. 1) The absorption, distribution and excretion of ginsenoside Rg1 in the rat. Chem. Pharm. Bull. 1983; 31: 292–298
   PubMed Web of Science ®Google Scholar
• Porter C. J. H., Charman W. N. Uptake of drugs into the intestinal lymphatics after oral administration. Adv. Drug Deliv. Rev. 1997; 25: 71–89
   Web of Science ®Google Scholar
• Sasaki K., Yonebayashi S., Yoshida M., Shimizu K., Aotsuka T., Takayama K. Improvement in the bioavailability of poorly absorbed glycyrrhizin via various non-vascular administration routes in rats. Int. J. Pharm. 2003; 265: 95–102
   PubMed Web of Science ®Google Scholar
• Shen Y. J. Pharmacology of traditional Chinese medicine. Renmin Weisheng Press, BeijingChina 2000
   Google Scholar
• Swenson E. S., Curatolo W. J. Means to enhance penetration intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity. Adv. Drug Deliv. Rev. 1992; 8: 39–92
   Web of Science ®Google Scholar
• Takino Y. Studies on the pharmacodynamics of ginsenoside-Rg1, -Rb1 and -Rb2 in rats. Yakugaku Zasshi 1994; 114: 550–564
   PubMed Web of Science ®Google Scholar
• Takino Y., Odani T., Tanizawa H., Hayashi T. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. I. 1). Quantitative analysis of ginsenoside Rg1 in rats. Chem. Pharm. Bull. 1982; 30: 2196–2201
   PubMed Web of Science ®Google Scholar
• Ueda I., Shimojo F., Kozatani J. Effect of ethyl cellulose in a medium-chain triglyceride on the bioavailability of ceftizoxime. J. Pharm. Sci. 1983; 72: 454–458
   PubMed Web of Science ®Google Scholar
• Unowsky J., Behl C. R., Beskid G., Sattler J., Halpern J., Cleeland R. Effect of medium chain glycerides on enteral and rectal absorption of beta- 1actam and aminoglycoside antibiotics. Chemotherapy 1988; 34: 272–276
   PubMed Web of Science ®Google Scholar
• Yanyu X., Yunmei S., Zhipeng C., Qineng P. The preparation of silybin–phospholipid complex and the study on its pharmacokinetics in rats. Int. J. Pharm. 2006; 307: 77–82
   PubMed Web of Science ®Google Scholar
• Yeh P.-Y., Berenson M. M., Samowitz W. S., Kova P. K., Kopecek J. I. Site-specific drug delivery and penetration enhancement in the gastrointestinal tract. J. Control. Release 1995; 36: 109–124
   Web of Science ®Google Scholar
• Zheng G. Z. Biology and application of Panax notoginseng. Science Press, BeijingChina 1994
   Google Scholar